复合乳酸菌胶囊对腹泻型肠易激综合征患者的效果观察

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo observe the feasibility and effectiveness of Lactobacillus Complex Capsules in the treatment of diarrhea predominant irritable bowel syndrome(IBS).MethodsAltogether 105 cases of patients with diarrhea predominant IBS who were treated in our hospital from July 2015 to December 2016 were selected as the subject of this observation and divided into two groups according to clinical treatment,including 51 cases in the control group(treated with medications Berberine hydrochloride+Montmorillonite powder)and 54 cases in the study group(Lactobacillus Complex Capsules+Montmorillonite powder+Berberine hydrochloride).The improved time of diarrhea,abdominal distension and abdominal pain symptoms was compared statistically;assessment of two groups of IBS treatment,medication adverse events recorded during treatment,follow-up recurrence 6 months the number of disease statistics.Resultsthe cure rate and the recurrence rate was 96.3%,5.5%,84.3%in the control group,15.7%group comparison study group treatment effect,low recurrence rate,the difference was statistically significant(P＜0.05);adverse event statistics,the study group the incidence rate was 11.1%compared with the control group 7.8%,the difference was not statistically significant(P＞0.05);the study group diarrhea,abdominal distension,abdominal pain symptoms improved with time was shorter than the control group,the difference was statistically significant(P＜0.05).ConclusionThe clinical use of Lactobacillus Complex Capsules in the treatment of diarrhea type IBS patients is good,the disease recurrence rate is low,the symptoms are improved and the time is short.

Key words： Curative effect IBS Lactobacillus Complex Capsules Diarrhea type

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HE Gui-ming
	MO Bi-hua
	HUANG Zheng
	HUANG Xue-qin

Cite this article:

HE Gui-ming,MO Bi-hua,HUANG Zheng, et al. Observation of effect of Lactobacillus Complex Capsules on diarrhea predominant irritable bowel syndrome[J]. 中国当代医药, 2017, 24(32): 127-129.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I32/127

[11]	安玉良.复合乳酸菌胶囊联合黛力新治疗腹泻型肠易激综合征疗效观察[J].卫生职业教育，2012，30（16）：136-137.
[1]	田华，汪和明，黄艳春，等.米氮平联合奥替溴铵及复合乳酸菌胶囊治疗难治性腹泻型肠易激综合征的疗效观察[J].北方药学，2015，12（8）：138-139.
[2]	田华，汪和明，黄艳春，等.米氮平在难治性腹泻型肠易激综合征治疗中的应用[J].山东医药，2015，55（26）：66-67.
[3]	尹小宁.双歧三联活菌、蒙脱石散联合氟哌噻吨美利曲辛治疗腹泻型肠易激综合征的临床效果观察[J].中国当代医药，2014，21（34）：89-91.
[4]	许静亚.复方阿嗪米特联合复合乳酸菌胶囊治疗腹泻型肠易激综合征临床疗效观察[J].中国血液流变学杂志，2014，24（2）：235-236.
[5]	尚明霞，朱孔平.蒙脱石散联合抗炎药物治疗腹泻型肠易激综合征的效果分析[J].医学理论与实践，2015，28（18）：2474-2475.
[6]	梁海清，王世和.痛泻宁颗粒联合培菲康治疗感染后肠易激综合征的临床研究[J].重庆医学，2013，42（32）：3898-3899.
[7]	刘慧敏，陈富超，朱雪松，等.国内曲美布汀联用氟哌噻吨美利曲辛治疗肠易激综合征疗效和安全性的Meta分析[J].安徽医药，2013，17（12）：2125-2128.
[8]	李志华.复合乳酸菌胶囊联合乳果糖治疗便秘型肠易激综合征的疗效观察[J].现代医院，2013，13（10）：40-41.
[9]	丁光伟.美常安和蒙脱石散联合黛力新治疗腹泻型肠易激综合征临床疗效观察[J].中国现代药物应用，2012，6（20）：42-43.
[10]	田徐露，曹芝君，陈胜良，等.氟哌噻吨美利曲辛联合其他药物治疗肠易激综合征疗效的Meta分析[J].中华消化杂志，2012，32（7）：469-472.
[12]	郭君.曲美布汀联合双歧三联活菌治疗肠易激综合征的Meta 分析[J].安徽医药，2012，16（1）：91-94.
[13]	王东海，刘建勇，李慧国，等.长短疗程黛立新联合活菌制剂治疗肠易激综合征的对比[J].实用医学杂志，2012，28（6）：984-985.
[14]	王谦，朱雁兵，赵东杰，等.马来酸曲美布汀、谷维素联合山莨菪碱治疗IBS78例效果观察[J].山东医药，2012，52（3）：96-97.
[15]	鲁大林.曲美布汀联合金双歧治疗肠易激综合征患者的临床观察[J].安徽医药，2012，16（5）：676-677.